ID
26088
Beschrijving
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00617942
Link
https://clinicaltrials.gov/show/NCT00617942
Trefwoorden
Versies (1)
- 09-10-17 09-10-17 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 oktober 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00617942
Eligibility Breast Cancer NCT00617942
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00617942
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C3714786 (UMLS CUI [3])
C3258246 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C1515119 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1514873 (UMLS CUI [1,2])
C1514471 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1512413 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0521317 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
C1516728 (UMLS CUI [1,2])
C0021044 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1977461 (UMLS CUI [3])